SCHISANDRA
Traditional Chinese adaptogenic berry rich in lignans with hepatoprotective, neuroprotective, and antioxidant properties.
Schisandra chinensis has centuries of traditional use and is a pharmacopoeial species in China. Clinical studies show SF-derived drugs effectively reduce drug-induced liver injury markers (ALT, AST, bilirubin). Preclinical research demonstrates hepatoprotective, neuroprotective, cardioprotective, anti-inflammatory, and anticancer properties, primarily attributed to dibenzocyclooctadiene lignans. Evidence for cognitive enhancement and adaptogenic effects in humans is limited, with most data from animal models. High-quality randomized controlled trials remain scarce, and clinical efficacy for many claimed indications is insufficiently validated.